Joseph J Valorose, Jr

Title: Joseph J Valorose, Jr: Innovator in Pharmaceutical Delivery Systems

Introduction

Joseph J Valorose, Jr. is a notable inventor based in Montgomery, NY (US). He has made significant contributions to the field of pharmaceutical delivery systems, holding a total of 5 patents. His work focuses on innovative methods to enhance the delivery and effectiveness of medications.

Latest Patents

Valorose's latest patents include advanced pulsatile once-a-day delivery systems for minocycline. These pharmaceutical delivery systems utilize 7-dimethyl-6-deoxy-6-demethyltetracycline or its non-toxic acid addition salt. The systems are designed to release minocycline in a medium with a pH ranging from about 4.0 to about 7.5, utilizing pH-sensitive polymer-coated spherical granules. Additionally, they include quick-release granules that release minocycline in a medium with a pH of less than about 3.9. These formulations ensure that therapeutic blood levels of minocycline are maintained for at least 24 hours with a single daily administration.

Another patent focuses on a similar pulsatile delivery system, which combines slow-release blended polymer-coated spherical granules with quick-release granules. This innovative approach provides enhanced therapeutic blood levels of minocycline, regardless of whether the patient is fed or fasted. Methods for preparing these systems and formulations are also included in his patents.

Career Highlights

Joseph J Valorose, Jr. is associated with the American Cyanamid Company, where he has contributed to the development of groundbreaking pharmaceutical technologies. His expertise in drug delivery systems has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Valorose has collaborated with notable colleagues, including Nitin V Sheth and Keith A Ellway. These partnerships have fostered innovation and advancement in pharmaceutical research and development.

Conclusion

Joseph J Valorose, Jr. is a distinguished inventor whose work in pharmaceutical delivery systems has made a significant impact on medication administration. His innovative approaches continue to enhance therapeutic outcomes for patients.